KEGG   PATHWAY: ssc05200
Entry
ssc05200                    Pathway                                
Name
Pathways in cancer - Sus scrofa (pig)
Class
Human Diseases; Cancer: overview
Pathway map
ssc05200  Pathways in cancer
ssc05200

Organism
Sus scrofa (pig) [GN:ssc]
Gene
100152102  DCC; netrin receptor DCC isoform X4 [KO:K06765]
397244  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
100518913  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
100188978  APPL1; DCC-interacting protein 13-alpha [KO:K08733]
100048953  CDH1; cadherin-1 precursor [KO:K05689]
397657  CTNNB1; catenin beta-1 [KO:K02105]
100153974  CTNNA3; catenin alpha-3 isoform X7 [KO:K05691]
100525337  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
100523778  CTNNA1; catenin alpha-1 [KO:K05691]
100523725  AXIN1; axin-1 isoform X1 [KO:K02157]
100739604  AXIN2; axin-2 isoform X1 [KO:K04385]
100517932  APC; adenomatous polyposis coli protein [KO:K02085]
100579172  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
100126852  GSK3B; glycogen synthase kinase-3 beta [KO:K03083] [EC:2.7.11.26]
100512951  TCF7; transcription factor 7 isoform X1 [KO:K02620]
100523899  TCF7L1; LOW QUALITY PROTEIN: transcription factor 7-like 1 [KO:K04490]
100153922  TCF7L2; transcription factor 7-like 2 isoform X26 [KO:K04491]
100170126  LEF1; lymphoid enhancer-binding factor 1 [KO:K04492]
397266  BIRC5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
448810  MYC; myc proto-oncogene protein [KO:K04377]
100738589  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
100525462  WNT1; proto-oncogene Wnt-1 [KO:K03209]
100516839  WNT2; protein Wnt-2 [KO:K00182]
100520560  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
100514950  WNT3A; protein Wnt-3a isoform X1 [KO:K00312]
100519512  WNT3; proto-oncogene Wnt-3 isoform X1 [KO:K00312]
100327037  WNT4; protein Wnt-4 [KO:K00408]
100516268  WNT5B; LOW QUALITY PROTEIN: protein Wnt-5b [KO:K00444]
100627056  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
100622044  WNT6; protein Wnt-6 [KO:K00445]
100153445  WNT7A; protein Wnt-7a [KO:K00572]
100626947  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
100513655  WNT8B; protein Wnt-8b isoform X1 [KO:K00714]
100739710  WNT8A; protein Wnt-8a [KO:K00714]
100512949  WNT9A; protein Wnt-9a [KO:K01064]
100738655  WNT9B; protein Wnt-9b [KO:K01064]
100126276  WNT10B; protein Wnt-10b precursor [KO:K01357]
100623646  WNT10A; LOW QUALITY PROTEIN: protein Wnt-10a [KO:K01357]
100521912  WNT11; protein Wnt-11 [KO:K01384]
100511484  WNT16; protein Wnt-16 [KO:K01558]
100513691  FZD7; frizzled-7 [KO:K02432]
110262227  FZD1; frizzled-1 [KO:K02432]
100337669  FZD2; frizzled-2 precursor [KO:K02235]
100153078  FZD3; frizzled-3 isoform X1 [KO:K02329]
100520319  FZD4; LOW QUALITY PROTEIN: frizzled-4 [KO:K02354]
100519058  FZD5; frizzled-5 [KO:K02375]
110255708  FZD8; LOW QUALITY PROTEIN: frizzled-8 [KO:K02375]
100157360  FZD6; frizzled-6 precursor [KO:K02376]
100511782  FZD10; frizzled-10 [KO:K02842]
100625784  FZD9; frizzled-9 [KO:K02842]
100515777  LRP6; LOW QUALITY PROTEIN: low-density lipoprotein receptor-related protein 6 [KO:K03068]
100524299  LRP5; low-density lipoprotein receptor-related protein 5 isoform X1 [KO:K03068]
100525170  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X2 [KO:K02353]
100621038  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
100625452  DVL2; LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
110256598  FRAT1; proto-oncogene FRAT1 [KO:K03069]
110256599  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
100144442  F2; prothrombin precursor [KO:K01313] [EC:3.4.21.5]
100157073  AGT; angiotensinogen [KO:K09821]
100521609  F2R; proteinase-activated receptor 1 precursor [KO:K03914]
100514949  F2RL3; proteinase-activated receptor 4 [KO:K04236]
100512581  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]
100038015  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
100113360  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]
100038017  LPAR4; lysophosphatidic acid receptor 4 isoform X1 [KO:K04275]
102161415  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
100738399  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
100519976  AGTR1; type-1 angiotensin II receptor [KO:K04166]
100525156  GNA12; guanine nucleotide-binding protein subunit alpha-12 isoform X1 [KO:K04346]
100522824  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
100523324  ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X5 [KO:K07532]
100157291  ARHGEF11; rho guanine nucleotide exchange factor 11 isoform X1 [KO:K12331]
100518073  ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X11 [KO:K12330]
100516377  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
396849  RHOA; transforming protein RhoA [KO:K04513]
397447  ROCK1; rho-associated protein kinase 1 [KO:K04514] [EC:2.7.11.1]
397445  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
494460  CXCL12; stromal cell-derived factor 1 precursor [KO:K10031]
396659  CXCR4; C-X-C chemokine receptor type 4 [KO:K04189]
100144421  GNAI3; guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630]
100144419  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
397523  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
100515879  PTGER1; prostaglandin E2 receptor EP1 subtype isoform X1 [KO:K04258]
100127164  PTGER2; prostaglandin E2 receptor EP2 subtype [KO:K04259]
396811  PTGER3; prostaglandin E2 receptor EP3 subtype [KO:K04260]
100625072  PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
100049657  GNAS; SCG6 (secretogranin VI) isoform SCG6 [KO:K04632]
100624934  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
100517503  ADCY2; LOW QUALITY PROTEIN: adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
100514402  ADCY3; adenylate cyclase type 3 [KO:K08043] [EC:4.6.1.1]
100152067  ADCY4; adenylate cyclase type 4 [KO:K08044] [EC:4.6.1.1]
100155970  ADCY5; adenylate cyclase type 5 isoform X1 [KO:K08045] [EC:4.6.1.1]
100522613  ADCY6; LOW QUALITY PROTEIN: adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
100620994  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
100622999  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
100625423  ADCY9; adenylate cyclase type 9 isoform X1 [KO:K08049] [EC:4.6.1.1]
397652  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
100623628  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
110261346  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
100516546  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
100154522  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
100524280  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
100157949  GNB5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
102165618  GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
100620948  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 isoform X1 [KO:K04540]
102167388  GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
102166994  GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
100621275  GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
100622520  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 isoform X1 [KO:K04544]
100515992  GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 isoform X1 [KO:K04545]
100522202  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
100270820  GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
100520008  GNG14; uncharacterized LOC105372280 homolog [KO:K04347]
100511870  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
100519790  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 isoform X1 [KO:K04548]
100621431  uncharacterized protein LOC100621431 isoform X1 [KO:K04549]
110255211  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 isoform X2 [KO:K04549]
100153454  COL4A2; collagen alpha-2(IV) chain [KO:K06237]
100515336  COL4A1; LOW QUALITY PROTEIN: collagen alpha-1(IV) chain [KO:K06237]
100620724  COL4A6; LOW QUALITY PROTEIN: collagen alpha-6(IV) chain [KO:K06237]
100621403  COL4A4; LOW QUALITY PROTEIN: collagen alpha-4(IV) chain [KO:K06237]
100621504  COL4A3; LOW QUALITY PROTEIN: collagen alpha-3(IV) chain [KO:K06237]
100737091  COL4A5; collagen alpha-5(IV) chain isoform X1 [KO:K06237]
100154420  LAMA2; LOW QUALITY PROTEIN: laminin subunit alpha-2 [KO:K05637]
100625589  LAMA1; LOW QUALITY PROTEIN: laminin subunit alpha-1 [KO:K05637]
100511642  LAMA3; laminin subunit alpha-3 isoform X1 [KO:K06240]
110257482  LAMA5; laminin subunit alpha-5 isoform X1 [KO:K06240]
100154581  LAMA4; LOW QUALITY PROTEIN: laminin subunit alpha-4 [KO:K06241]
396707  LAMB1; LOW QUALITY PROTEIN: laminin subunit beta-1 [KO:K05636]
101101688  LAMB2; laminin subunit beta-2 [KO:K06243]
100736655  LAMB3; LOW QUALITY PROTEIN: laminin subunit beta-3 [KO:K06244]
100623759  LAMB4; LOW QUALITY PROTEIN: laminin subunit beta-4 [KO:K06245]
100514785  LAMC1; laminin subunit gamma-1 precursor [KO:K05635]
100624264  LAMC2; laminin subunit gamma-2 [KO:K06246]
100157958  LAMC3; LOW QUALITY PROTEIN: laminin subunit gamma-3 [KO:K06247]
397620  FN1; LOW QUALITY PROTEIN: fibronectin [KO:K05717]
397483  ITGA2; integrin alpha-2 precursor [KO:K06481]
397059  ITGA2B; integrin alpha-IIb precursor [KO:K06476]
100517053  ITGA3; integrin alpha-3 [KO:K06482]
100158200  ITGA6; LOW QUALITY PROTEIN: integrin alpha-6 [KO:K06485]
397285  ITGAV; integrin alpha-V precursor [KO:K06487]
397019  ITGB1; integrin beta-1 precursor [KO:K05719]
102167153  PTK2; focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
100518131  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
100621789  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
100622559  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
100511937  phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
100739510  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
100623707  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2 [KO:K02649]
100156264  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
100738625  NKX3-1; homeobox protein Nkx-3.1 [KO:K09348]
100126861  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100513811  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100127478  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100135662  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha [KO:K04467] [EC:2.7.11.10]
100101471  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
100127355  IKBKG; NF-kappa-B essential modulator [KO:K07210]
406188  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
751869  NFKB1; nuclear factor NF-kappa-B p105 subunit [KO:K02580]
100153829  NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
100135665  RELA; transcription factor p65 [KO:K04735]
397590  PTGS2; prostaglandin G/H synthase 2 precursor [KO:K11987] [EC:1.14.99.1]
396859  NOS2; nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
100049703  BCL2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
100622859  baculoviral IAP repeat-containing protein 2 isoform X1 [KO:K16060]
100622590  BIRC3; LOW QUALITY PROTEIN: baculoviral IAP repeat-containing protein 3 [KO:K16060]
100037300  XIAP; E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
110257375  BIRC7; baculoviral IAP repeat-containing protein 7 isoform X1 [KO:K16061]
397536  BCL2L1; bcl-2-like protein 1 [KO:K04570]
100627029  TRAF1; TNF receptor-associated factor 1 [KO:K03172]
100513840  TRAF2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
100156979  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
100518396  TRAF4; TNF receptor-associated factor 4 [KO:K09848]
396616  TRAF5; TNF receptor-associated factor 5 isoform X2 [KO:K09849]
396629  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
100127359  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
100127158  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
100512153  RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
100521065  BAD; LOW QUALITY PROTEIN: bcl2-associated agonist of cell death [KO:K02158]
397077  FOXO1; forkhead box protein O1 [KO:K07201]
100125959  MDM2; E3 ubiquitin-protein ligase Mdm2 [KO:K06643] [EC:2.3.2.27]
397276  TP53; cellular tumor antigen p53 [KO:K04451]
397584  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
100152215  CDKN1A; LOW QUALITY PROTEIN: cyclin-dependent kinase inhibitor 1 [KO:K06625]
100157974  BCR; breakpoint cluster region protein isoform X1 [KO:K08878] [EC:2.7.11.1]
100524544  ABL1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
100192444  CRK; adapter molecule crk [KO:K04438]
100525363  CRKL; crk-like protein [KO:K04438]
100518854  CBL; E3 ubiquitin-protein ligase CBL isoform X1 [KO:K04707] [EC:2.3.2.27]
397550  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]
397340  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]
100157844  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
100621339  PIM2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
396568  KNG1; kininogen-1 isoform X2 [KO:K03898]
396915  EDN1; endothelin-1 preproprotein [KO:K16366]
100127469  BDKRB1; B1 bradykinin receptor [KO:K03915]
110255240  BDKRB2; B2 bradykinin receptor isoform X2 [KO:K03916]
397457  EDNRA; endothelin-1 receptor precursor [KO:K04197]
414911  EDNRB; endothelin B receptor precursor [KO:K04198]
654405  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
733588  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
100152679  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
100157641  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
100516581  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
100525148  PLCB3; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
397184  PRKCA; LOW QUALITY PROTEIN: protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
100522792  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
100518074  PRKCG; protein kinase C gamma type isoform X3 [KO:K19663] [EC:2.7.11.13]
396868  IL2; interleukin-2 precursor [KO:K05429]
397225  IL4; interleukin-4 precursor [KO:K05430]
397409  IL5; interleukin-5 precursor [KO:K05428]
399500  IL6; interleukin-6 precursor [KO:K05405]
397253  IL7; interleukin-7 precursor [KO:K05431]
397053  IL12A; interleukin-12 subunit alpha [KO:K05406]
397076  IL12B; interleukin-12 subunit beta precursor [KO:K05425]
396721  IL13; interleukin-13 precursor [KO:K05435]
397683  IL15; interleukin-15 precursor [KO:K05433]
100155546  IL23A; interleukin-23 subunit alpha precursor [KO:K05426]
397249  EPO; erythropoietin precursor [KO:K05437]
397686  IFNA1; interferon alpha-1 precursor [KO:K05414]
100153724  IFN-ALPHA-8; uncharacterized protein LOC100153724 precursor [KO:K05414]
100153661  interferon alpha-14 precursor [KO:K05414]
100157766  IFN-ALPHA-9; uncharacterized protein LOC100157766 precursor [KO:K05414]
100152100  IFN-ALPHA-13; uncharacterized protein LOC100152100 precursor [KO:K05414]
100152504  IFN-ALPHA-15; uncharacterized protein LOC100152504 precursor [KO:K05414]
100310806  IFN-ALPHAOMEGA; interferon-alphaomega precursor [KO:K05414]
100303758  IFN-ALPHA-5; interferon, alpha 5 precursor [KO:K05414]
100157735  IFN-ALPHA-16; uncharacterized protein LOC100157735 precursor [KO:K05414]
100153325  interferon alpha-2 precursor [KO:K05414]
100737904  interferon alpha-1-like [KO:K05414]
100154938  IFN-ALPHA-17; uncharacterized protein LOC100154938 precursor [KO:K05414]
100156561  IFN-ALPHA-10; interferon-alpha-10 precursor [KO:K05414]
100156936  interferon alpha-11 precursor [KO:K05414]
100157352  IFN-ALPHA-1; interferon-alpha-1 precursor [KO:K05414]
396991  IFNG; interferon gamma precursor [KO:K04687]
396814  IL2RA; interleukin-2 receptor subunit alpha precursor [KO:K05068]
100621776  IL2RB; interleukin-2 receptor subunit beta isoform X1 [KO:K05069]
397156  IL2RG; cytokine receptor common subunit gamma precursor [KO:K05070]
397614  IL4R; interleukin-4 receptor subunit alpha precursor [KO:K05071]
100153254  CSF2RB; cytokine receptor common subunit beta [KO:K04738]
100137085  IL5RA; interleukin-5 receptor subunit alpha isoform X2 [KO:K05067]
399522  IL6R; interleukin-6 receptor subunit alpha precursor [KO:K05055]
100037294  IL6ST; interleukin-6 receptor subunit beta precursor [KO:K05060]
100271930  IL7R; interleukin-7 receptor subunit alpha precursor [KO:K05072]
100271900  IL12RB1; interleukin-12 receptor subunit beta-1 precursor [KO:K05063]
397178  IL12RB2; interleukin-12 receptor subunit beta-2 precursor [KO:K05064]
397615  IL13RA1; interleukin-13 receptor subunit alpha-1 precursor [KO:K05076]
733692  IL15RA; interleukin-15 receptor subunit alpha isoform X2 [KO:K05074]
733613  IL23R; interleukin-23 receptor [KO:K05065]
397554  EPOR; erythropoietin receptor precursor [KO:K05079]
396658  IFNAR1; interferon alpha/beta receptor 1 precursor [KO:K05130]
100533555  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
100152238  IFNGR1; interferon gamma receptor 1 precursor [KO:K05132]
100126864  IFNGR2; interferon gamma receptor 2 precursor [KO:K05133]
100515021  EML4; echinoderm microtubule-associated protein-like 4 isoform X3 [KO:K15420]
100518423  ALK; ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
100522721  RASGRP1; RAS guanyl-releasing protein 1 isoform X1 [KO:K04350]
100626093  RASGRP2; RAS guanyl-releasing protein 2 [KO:K12361]
100511446  RASGRP3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
100516199  RASGRP4; RAS guanyl-releasing protein 4 [KO:K12363]
397202  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
397201  JAK2; tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
100518649  JAK3; tyrosine-protein kinase JAK3 isoform X1 [KO:K11218] [EC:2.7.10.2]
733648  STAT3; signal transducer and activator of transcription 3 [KO:K04692]
396655  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
396923  STAT2; signal transducer and activator of transcription 2 [KO:K11221]
397261  STAT4; signal transducer and activator of transcription 4 [KO:K11222]
100153518  STAT6; signal transducer and activator of transcription 6 isoform 1 [KO:K11225]
397157  VEGFA; vascular endothelial growth factor A precursor [KO:K05448]
100521837  VEGFB; vascular endothelial growth factor B isoform X2 [KO:K16858]
100156404  PGF; placenta growth factor isoform X1 [KO:K16859]
100155670  VEGFD; vascular endothelial growth factor D [KO:K05449]
397484  TGFA; protransforming growth factor alpha precursor [KO:K08774]
397083  EGF; pro-epidermal growth factor precursor [KO:K04357]
397070  EGFR; epidermal growth factor receptor precursor [KO:K04361] [EC:2.7.10.1]
100516641  ERBB2; receptor tyrosine-protein kinase erbB-2 precursor [KO:K05083] [EC:2.7.10.1]
100519764  PDGFA; platelet-derived growth factor subunit A isoform X5 [KO:K04359]
100627123  PDGFRA; platelet-derived growth factor receptor alpha precursor [KO:K04363] [EC:2.7.10.1]
102166564  PDGFRB; platelet-derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
397491  IGF1; insulin-like growth factor I precursor [KO:K05459]
396916  IGF2; insulin-like growth factor II preproprotein [KO:K13769]
397350  IGF1R; insulin-like growth factor 1 receptor precursor [KO:K05087] [EC:2.7.10.1]
397509  KITLG; kit ligand precursor [KO:K05461]
396810  KIT; mast/stem cell growth factor receptor Kit precursor [KO:K05091] [EC:2.7.10.1]
100515445  FLT3; receptor-type tyrosine-protein kinase FLT3 isoform X2 [KO:K05092] [EC:2.7.10.1]
100525120  HGF; hepatocyte growth factor isoform X3 [KO:K05460]
654328  MET; hepatocyte growth factor receptor precursor [KO:K05099] [EC:2.7.10.1]
397497  FGF1; fibroblast growth factor 1 [KO:K18496]
397643  FGF2; fibroblast growth factor 2 [KO:K18497]
396717  FGF9; fibroblast growth factor 9 [KO:K04358]
100155720  FGF17; fibroblast growth factor 17 [KO:K04358]
100152116  FGF6; fibroblast growth factor 6 [KO:K04358]
100152223  FGF16; fibroblast growth factor 16 [KO:K04358]
100156242  FGF8; LOW QUALITY PROTEIN: fibroblast growth factor 8 [KO:K04358]
100513672  FGF5; fibroblast growth factor 5 isoform X1 [KO:K04358]
100516301  FGF20; fibroblast growth factor 20 [KO:K04358]
100518595  FGF4; fibroblast growth factor 4 [KO:K04358]
100519127  FGF3; fibroblast growth factor 3 [KO:K04358]
100525013  FGF18; fibroblast growth factor 18 isoform X2 [KO:K04358]
100525086  FGF10; fibroblast growth factor 10 [KO:K04358]
397281  FGF7; fibroblast growth factor 7 [KO:K04358]
110259378  FGF22; fibroblast growth factor 22 [KO:K04358]
100518950  FGF19; fibroblast growth factor 19 [KO:K22603]
100302504  FGF21; fibroblast growth factor 21 precursor [KO:K22429]
100155339  FGF23; fibroblast growth factor 23 [KO:K22428]
100153248  FGFR1; LOW QUALITY PROTEIN: fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
396762  FGFR2; fibroblast growth factor receptor 2 precursor [KO:K05093] [EC:2.7.10.1]
100514115  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
100127133  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
100192436  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
100156602  SOS2; son of sevenless homolog 2 [KO:K03099]
100520187  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
110259208  HRAS; GTPase HRas isoform X1 [KO:K02833]
100518251  KRAS; GTPase KRas isoform X2 [KO:K07827]
100739349  NRAS; GTPase NRas precursor [KO:K07828]
397601  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
100514612  BRAF; serine/threonine-protein kinase B-raf isoform X6 [KO:K04365] [EC:2.7.11.1]
100737448  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
100233191  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100525505  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
100153927  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
445013  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
396913  JUN; transcription factor AP-1 [KO:K04448]
100144486  FOS; proto-oncogene c-Fos [KO:K04379]
100302363  ETS1; protein C-ets-1 [KO:K02678]
397320  MMP1; interstitial collagenase precursor [KO:K01388] [EC:3.4.24.7]
397391  MMP2; 72 kDa type IV collagenase precursor [KO:K01398] [EC:3.4.24.24]
654325  MMP9; matrix metalloproteinase-9 precursor [KO:K01403] [EC:3.4.24.35]
396880  CXCL8; interleukin-8 precursor [KO:K10030]
100144492  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
100623751  RPS6KA5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
100155053  RET; LOW QUALITY PROTEIN: proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
100155896  CCDC6; coiled-coil domain-containing protein 6 [KO:K09288]
100156184  NCOA4; nuclear receptor coactivator 4 [KO:K09289]
100154471  NTRK1; high affinity nerve growth factor receptor [KO:K03176] [EC:2.7.10.1]
414388  TPM3; tropomyosin alpha-3 chain [KO:K09290]
100520507  TPR; nucleoprotein TPR isoform X2 [KO:K09291]
414406  TFG; protein TFG isoform X1 [KO:K09292]
100516830  RASSF1; ras association domain-containing protein 1 isoform X2 [KO:K09850]
100521638  RASSF5; ras association domain-containing protein 5 isoform X1 [KO:K08015]
100517317  STK4; serine/threonine-protein kinase 4 isoform X1 [KO:K04411]
100155578  DAPK2; death-associated protein kinase 2 [KO:K08803] [EC:2.7.11.1]
100516103  DAPK1; death-associated protein kinase 1 isoform X1 [KO:K08803] [EC:2.7.11.1]
100624415  DAPK3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
100152497  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
100518663  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
100522002  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
100154056  CALM1; calmodulin [KO:K02183]
396838  CALM3; calmodulin [KO:K02183]
100522926  CALM2; calmodulin [KO:K02183]
100738118  CALML5; calmodulin-like protein 5 [KO:K02183]
100623661  CALML6; LOW QUALITY PROTEIN: calmodulin-like protein 6 [KO:K02183]
100519528  CALML4; calmodulin-like 4 [KO:K02183]
397674  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta [KO:K04515] [EC:2.7.11.17]
397394  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma [KO:K04515] [EC:2.7.11.17]
100626014  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X7 [KO:K04515] [EC:2.7.11.17]
100516166  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
100513970  RALGDS; ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732]
100622254  RALA; ras-related protein Ral-A isoform X2 [KO:K07834]
100624229  RALB; ras-related protein Ral-B [KO:K07835]
100519155  RALBP1; ralA-binding protein 1 [KO:K08773]
780428  CDC42; cell division control protein 42 homolog [KO:K04393]
100627149  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
100621675  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
110255928  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
100519446  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]
414900  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
396610  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
100521736  MAPK10; mitogen-activated protein kinase 10 isoform X3 [KO:K04440] [EC:2.7.11.24]
396609  MAPK9; mitogen-activated protein kinase 9 isoform X4 [KO:K04440] [EC:2.7.11.24]
397671  PPARG; peroxisome proliferator-activated receptor gamma [KO:K08530]
397306  RXRA; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
100156801  RXRB; retinoic acid receptor RXR-beta [KO:K08525]
445465  RXRG; retinoic acid receptor RXR-gamma [KO:K08526]
396710  RARB; LOW QUALITY PROTEIN: retinoic acid receptor beta [KO:K08528]
397435  ESR1; estrogen receptor [KO:K08550]
396697  ESR2; estrogen receptor beta [KO:K08551]
574068  NCOA1; nuclear receptor coactivator 1 [KO:K09101] [EC:2.3.1.48]
100135659  NCOA3; nuclear receptor coactivator 3 [KO:K11256] [EC:2.3.1.48]
396575  SP1; transcription factor Sp1 isoform X1 [KO:K04684]
397297  PPARD; peroxisome proliferator-activated receptor delta [KO:K04504]
397592  JUP; junction plakoglobin [KO:K10056]
100625290  ZBTB16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
396709  RARA; retinoic acid receptor alpha isoform X2 [KO:K08527]
100415929  CCNA2; cyclin-A2 [KO:K06627]
100156017  CCNA1; cyclin-A1 [KO:K06627]
100157336  PML; LOW QUALITY PROTEIN: protein PML [KO:K10054] [EC:2.3.2.-]
100512633  RUNX1; runt-related transcription factor 1 [KO:K08367]
100155449  RUNX1T1; LOW QUALITY PROTEIN: protein CBFA2T1 [KO:K10053]
414912  SPI1; transcription factor PU.1 [KO:K09438]
397307  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
100620339  CSF2RA; granulocyte-macrophage colony-stimulating factor receptor subunit alpha isoform X1 [KO:K05066]
100622336  CSF3R; granulocyte colony-stimulating factor receptor [KO:K05061]
100517086  CSF1R; macrophage colony-stimulating factor 1 receptor isoform X1 [KO:K05090] [EC:2.7.10.1]
100153846  E2F1; transcription factor E2F1 [KO:K17454]
110261113  E2F2; transcription factor E2F2 [KO:K09389]
100154407  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
100517170  MAX; protein max isoform X1 [KO:K04453]
100620358  ZBTB17; zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
397227  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
397162  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
780426  CCND3; G1/S-specific cyclin-D3 [KO:K10152]
100155110  CKS1B; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
100520933  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
100520183  LOW QUALITY PROTEIN: S-phase kinase-associated protein 1 [KO:K03094]
110259483  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
100524037  CUL1; cullin-1 [KO:K03347]
110260638  RBX1; E3 ubiquitin-protein ligase RBX1 isoform X1 [KO:K03868] [EC:2.3.2.32]
100329128  SKP2; S-phase kinase-associated protein 2 [KO:K03875]
100154715  CDK2; cyclin-dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
100512048  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
100523248  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
100151828  RB1; retinoblastoma-associated protein [KO:K06618]
100152997  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
733669  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
100621090  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
396633  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
397543  BAK1; bcl-2 homologous antagonist/killer isoform X2 [KO:K14021]
100513197  DDB2; DNA damage-binding protein 2 isoform X2 [KO:K10140]
100518650  POLK; LOW QUALITY PROTEIN: DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
492280  TERT; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]
414902  MITF; microphthalmia-associated transcription factor [KO:K09455]
397078  TGFB1; transforming growth factor beta-1 precursor [KO:K13375]
397084  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
397400  TGFB3; transforming growth factor beta-3 precursor [KO:K13377]
396665  TGFBR1; TGF-beta receptor type-1 precursor [KO:K04674] [EC:2.7.11.30]
100038019  TGFBR2; TGF-beta receptor type-2 [KO:K04388] [EC:2.7.11.30]
100155304  SMAD2; mothers against decapentaplegic homolog 2 [KO:K04500]
397260  SMAD3; mothers against decapentaplegic homolog 3 [KO:K23605]
397142  SMAD4; mothers against decapentaplegic homolog 4 [KO:K04501]
100518275  MECOM; MDS1 and EVI1 complex locus protein EVI1 isoform X1 [KO:K04462] [EC:2.1.1.367]
100154421  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
110262035  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
100156170  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
100622482  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
100337665  MLH1; DNA mismatch repair protein Mlh1 [KO:K08734]
100337661  MSH2; DNA mismatch repair protein Msh2 [KO:K08735]
100512158  MSH3; LOW QUALITY PROTEIN: DNA mismatch repair protein Msh3 [KO:K08736]
100624450  MSH6; DNA mismatch repair protein Msh6 isoform X2 [KO:K08737]
100624979  BRCA2; LOW QUALITY PROTEIN: breast cancer type 2 susceptibility protein [KO:K08775]
100141309  RAD51; DNA repair protein RAD51 homolog 1 [KO:K04482]
396726  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
396826  FAS; tumor necrosis factor receptor superfamily member 6 precursor [KO:K04390]
595129  FADD; FAS-associated death domain protein [KO:K02373]
595105  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
594852  BID; BH3-interacting domain death agonist [KO:K04726]
397278  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
100517403  BBC3; bcl-2-binding component 3 isoform X3 [KO:K10132]
396632  BCL2L11; bcl-2-like protein 11 isoform 2 [KO:K16341]
100170131  CYCS; cytochrome c [KO:K08738]
100522842  cytochrome c [KO:K08738]
100519295  cytochrome c-like [KO:K08738]
100621347  cytochrome c-like [KO:K08738]
100513283  APAF1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
100156777  CASP7; caspase-7 isoform X1 [KO:K04397] [EC:3.4.22.60]
100136900  KEAP1; kelch-like ECH-associated protein 1 [KO:K10456]
100516343  NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X4 [KO:K05638]
445512  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
100286873  NQO1; NAD(P)H dehydrogenase [quinone] 1 [KO:K00355] [EC:1.6.5.2]
397117  GSTO1; glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
397567  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
397682  GSTA1; glutathione S-transferase alpha M14 [KO:K00799] [EC:2.5.1.18]
100152951  GSTA4; glutathione S-transferase A4 [KO:K00799] [EC:2.5.1.18]
100153094  glutathione S-transferase theta-1 [KO:K00799] [EC:2.5.1.18]
780435  glutathione S-transferase mu 2 [KO:K00799] [EC:2.5.1.18]
733607  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
100152209  glutathione S-transferase omega-2 [KO:K00799] [EC:2.5.1.18]
100510917  glutathione S-transferase A4 [KO:K00799] [EC:2.5.1.18]
100514231  GSTM3; glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
100622296  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
106510200  glutathione S-transferase Mu 1 [KO:K00799] [EC:2.5.1.18]
100151901  glutathione S-transferase theta-4 [KO:K00799] [EC:2.5.1.18]
110260350  LOW QUALITY PROTEIN: glutathione S-transferase Mu 1-like [KO:K00799] [EC:2.5.1.18]
110260348  glutathione S-transferase Mu 1-like isoform X1 [KO:K00799] [EC:2.5.1.18]
100526118  glutathione S-transferase A1-like [KO:K00799] [EC:2.5.1.18]
100739163  glutathione S-transferase P-like isoform X1 [KO:K23790] [EC:2.5.1.18]
100739508  glutathione S-transferase P-like [KO:K23790] [EC:2.5.1.18]
396681  TXNRD1; thioredoxin reductase 1, cytoplasmic [KO:K22182] [EC:1.8.1.9]
100519799  TXNRD3; LOW QUALITY PROTEIN: thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
100156736  TXNRD2; thioredoxin reductase 2, mitochondrial [KO:K22182] [EC:1.8.1.9]
100739306  VHL; von Hippel-Lindau disease tumor suppressor [KO:K03871]
100153381  ELOC; elongin-C [KO:K03872]
100519651  ELOB; elongin-B [KO:K03873]
100512186  CUL2; cullin-2 [KO:K03870]
100152368  EGLN3; egl nine homolog 3 [KO:K09592] [EC:1.14.11.29]
100153461  EGLN1; egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
100523673  EGLN2; LOW QUALITY PROTEIN: egl nine homolog 2 [KO:K09592] [EC:1.14.11.29]
100627128  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
396696  HIF1A; hypoxia-inducible factor 1-alpha [KO:K08268]
100037272  EPAS1; endothelial PAS domain-containing protein 1 [KO:K09095]
396653  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
100157219  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 isoform X3 [KO:K15589]
100156226  EP300; LOW QUALITY PROTEIN: histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
100620215  CREBBP; CREB-binding protein [KO:K04498] [EC:2.3.1.48]
102164419  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
100156773  JAG1; protein jagged-1 isoform X2 [KO:K06052]
100522743  JAG2; protein jagged-2 isoform X1 [KO:K21635]
100152163  DLL4; delta-like protein 4 precursor [KO:K06051]
100520433  DLL3; delta-like protein 3 [KO:K06051]
100620481  DLL1; delta-like protein 1 isoform X1 [KO:K06051]
110258061  NOTCH1; neurogenic locus notch homolog protein 1 [KO:K02599]
100153369  NOTCH2; neurogenic locus notch homolog protein 2 isoform X1 [KO:K20994]
102158881  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
100144522  NOTCH4; neurogenic locus notch homolog protein 4 precursor [KO:K20996]
100499567  HES1; transcription factor HES-1 [KO:K06054]
110261433  HES5; transcription factor HES-5 [KO:K06055]
100152404  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 [KO:K09091]
100157952  HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X2 [KO:K09091]
100518256  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein isoform X1 [KO:K09091]
100518179  FLT4; vascular endothelial growth factor receptor 3 [KO:K05097] [EC:2.7.10.1]
100512749  SHH; sonic hedgehog protein preproprotein [KO:K11988]
100627504  PTCH1; protein patched homolog 1 isoform X1 [KO:K06225]
100515110  SMO; smoothened homolog [KO:K06226]
100624604  KIF7; kinesin-like protein KIF7 isoform X1 [KO:K18806]
100155412  SUFU; LOW QUALITY PROTEIN: suppressor of fused homolog [KO:K06229]
100520490  GLI1; zinc finger protein GLI1 [KO:K16797]
100520334  GLI2; zinc finger protein GLI2 [KO:K16798]
100516888  GLI3; transcriptional activator GLI3 isoform X1 [KO:K06230]
100157103  BMP2; bone morphogenetic protein 2 precursor [KO:K21283]
100113425  BMP4; bone morphogenetic protein 4 precursor [KO:K04662]
100525059  HHIP; hedgehog-interacting protein isoform X1 [KO:K06231]
100623280  PTCH2; protein patched homolog 2 isoform X1 [KO:K11101]
397582  AR; androgen receptor [KO:K08557]
397028  HSP90AA1; heat shock protein HSP 90-alpha [KO:K04079]
396742  HSP90AB1; heat shock protein HSP 90-beta [KO:K04079]
397191  HSP90B1; endoplasmin precursor [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
ssc03320  PPAR signaling pathway
ssc04010  MAPK signaling pathway
ssc04020  Calcium signaling pathway
ssc04024  cAMP signaling pathway
ssc04060  Cytokine-cytokine receptor interaction
ssc04066  HIF-1 signaling pathway
ssc04110  Cell cycle
ssc04115  p53 signaling pathway
ssc04150  mTOR signaling pathway
ssc04151  PI3K-Akt signaling pathway
ssc04210  Apoptosis
ssc04310  Wnt signaling pathway
ssc04330  Notch signaling pathway
ssc04340  Hedgehog signaling pathway
ssc04350  TGF-beta signaling pathway
ssc04370  VEGF signaling pathway
ssc04510  Focal adhesion
ssc04512  ECM-receptor interaction
ssc04520  Adherens junction
ssc04630  JAK-STAT signaling pathway
ssc04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system